Recent articles
The Real Reason First Solar is Dimming
Reluctance to embrace new technology is to blame for the company's eclipse.
Apple May Soon Market Flexible Tablets
Leaked memo hints at 7-inch "iPad mini," flexible screens in future models.
Can Fledgling Zynga Fly Without Facebook?
Zynga's beta platform may be the first tentative step toward leaving the Facebook nest.
Obama Accelerates Race for Alzheimer's Cure
An ambitious federal program aims to develop viable treatments for Alzheimer's disease.
3 Stocks Benefiting from Boomers Embracing Medicare
Managed-care companies are riding a wave of increased enrollment due to an aging U.S. population.
Is Apple's iPad 3 Debut Right Around the Corner?
The Apple rumor mill says the iPad 3 will arrive in the U.S. any day now.
Biosimilars: Big Pharma's Next Big Thing?
The Food and Drug Administration opens the floodgates to the manufacture of generic equivalents of biotech drugs.
Is Lampert the Cause or the Cure for Sears' Sickness?
Eddie Lampert has a plan, but the upshot is unclear.
Hefty Profits in Store for Obesity-Drug Makers
The Food and Drug Administration approves a weight-loss drug, despite misgivings.
Can True Religion Be Saved?
Despite the exalted profits being reported by most of the luxury retail sector, True Religion loses ground.
Apple Protects Its Core
Melding the MacBook Pro with MacBook Air to create the ultimate ultrabook would push Apple to the head of the line, again.
Whole Foods Market: A Steady Diet of Growth and Profit
A purveyor of pricey organic and natural products, Whole Foods Market has established itself as a grocer without peer -- with the profits to prove it.
Housing Recovery Comes Too Late for Private Builders
Smaller homebuilders are being squeezed out of existence by financing woes.